Other

Interest Income (Expense) And Other Nonoperating (Expense) Income, Net

West Pharmaceutical Services Interest Income (Expense) And Other Nonoperating (Expense) Income, Net decreased by 30.2% to $3.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 14.3%, from $3.50M to $3.00M.

Analysis

StatementIncome Statement
SectionOther
First reportedQ1 2024
Last reportedQ1 2026Apr 23, 2026
Metric ID: other_interest_income_expense_and_other_nonoperating_exp_5df3f3

Historical Data

7 periods
 Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$4.60M$2.50M$3.20M$3.50M$3.30M$4.30M$3.00M
QoQ Change—-45.7%+28.0%+9.4%-5.7%+30.3%-30.2%
YoY Change———-23.9%+32.0%+34.4%-14.3%
Range$2.50M – $4.60M
CAGR-24.8%
Avg YoY Growth+7.0%
Median YoY Growth+8.9%

Frequently Asked Questions

What is West Pharmaceutical Services's interest income (expense) and other nonoperating (expense) income, net?
West Pharmaceutical Services (WST) reported interest income (expense) and other nonoperating (expense) income, net of $3.00M in Q1 2026.
How has West Pharmaceutical Services's interest income (expense) and other nonoperating (expense) income, net changed year-over-year?
West Pharmaceutical Services's interest income (expense) and other nonoperating (expense) income, net decreased by 14.3% year-over-year, from $3.50M to $3.00M.